Pettee Investors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,500
Closed -$276K 116
2024
Q3
$276K Sell
6,500
-4,000
-38% -$210K 0.13% 109
2024
Q2
$538K Hold
10,500
0.26% 87
2024
Q1
$656K Hold
10,500
0.28% 84
2023
Q4
$786K Hold
10,500
0.35% 77
2023
Q3
$894K Hold
10,500
0.43% 68
2023
Q2
$1.15M Hold
10,500
0.52% 61
2023
Q1
$871K Hold
10,500
0.42% 71
2022
Q4
$1.08M Hold
10,500
0.53% 60
2022
Q3
$1.11M Hold
10,500
0.6% 56
2022
Q2
$1.15M Hold
10,500
0.57% 58
2022
Q1
$1.09M Hold
10,500
0.48% 65
2021
Q4
$1.28M Hold
10,500
0.54% 58
2021
Q3
$1.21M Hold
10,500
0.56% 55
2021
Q2
$1.02M Hold
10,500
0.48% 66
2021
Q1
$774K Hold
10,500
0.37% 74
2020
Q4
$717K Hold
10,500
0.38% 71
2020
Q3
$614K Hold
10,500
0.36% 70
2020
Q2
$475K Sell
10,500
-700
-6% -$33.5K 0.29% 78
2020
Q1
$647K Buy
11,200
+4,085
+57% +$280K 0.47% 61
2019
Q4
$443K Hold
7,115
0.25% 91
2019
Q3
$410K Hold
7,115
0.26% 91
2019
Q2
$386K Sell
7,115
-4,000
-36% -$203K 0.25% 96
2019
Q1
$523K Hold
11,115
0.33% 85
2018
Q4
$630K Hold
11,115
0.45% 66
2018
Q3
$608K Hold
11,115
0.36% 82
2018
Q2
$651K Buy
+11,115
New +$663K 0.41% 76

Other funds holding AMN

Pettee Investors's AMN Position: Q4 2024 in Review

Pettee Investors sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 6,500 shares — an estimated $276K sold.

Pettee Investors first reported a position in AMN in Q2 2018 and held it in 26 quarters. The position peaked at $1.28M in Q4 2021. 277 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Pettee Investors reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Pettee Investors sold 6,500 AMN Healthcare shares in Q4 2024, an estimated $276K.
  • Pettee Investors first reported a position in AMN Healthcare in Q2 2018 and held it in 26 quarters.
  • Pettee Investors's AMN Healthcare position peaked at $1.28M in Q4 2021.
  • 277 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Pettee Investors's 13F filing for Q4 2024, filed 7 Feb 2025.